Meeting
2018 Genitourinary Cancers Symposium
Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma.
Authors
Dominick Bosse
Dana-Farber Cancer Institute, Boston, MA
Dominick Bosse , Wanling Xie , Aly-Khan A. Lalani , Guillermo de Velasco , Martin Henner Voss , Nizar M. Tannir , Pheroze Tamboli , Leonard Joseph Appleman , Kimryn Rathmell , Daniel Yick Chin Heng , Guru Sonpavde , Sabina Signoretti , A. Ari Hakimi , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 626)
DOI
10.1200/JCO.2018.36.6_suppl.626
Abstract #
626
Poster Bd #
G19
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis.
First Author: Dominick Bossé
Poster
2023 ASCO Annual Meeting
Genomic determinants of progression-free survival after second line of therapy (PFS-2) for patients on immunotherapy-based combination therapies for advanced clear cell renal cell carcinoma.
First Author: Kelly N. Fitzgerald
Poster
2019 ASCO Quality Care Symposium
Efficacy of systemic treatment for metastatic renal cell carcinoma (mRCC) guided by comprehensive genomic profiling (CGP).
First Author: Paulo Gustavo Bergerot
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic alterations in metastatic renal cell carcinoma (mRCC): Impact on survival and clinical outcomes.
First Author: Jennifer King